This is a sign of the times.
In the spine sector, a stark imbalance persists: the pool of spine surgeons remains largely unchanged, while the number of device companies proliferates.
Hundreds compete for limited access to U.S. hospitals and ASCs, creating an increasingly saturated market.
This overcrowding empowers cash-rich firms to acquire assets from liquidity-strapped competitors, accelerating consolidation.
A recent example is Highridge's acquisition of spine assets from Accelus, underscoring the survival pressures on undercapitalized players.
To clarify, Accelus is gone. All employees w...
